Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) does not cause motion sickness in the clinical sense, but it does slow gastric emptying and can trigger nausea, dizziness and a general feeling of queasiness that some people describe as similar to travel sickness. These effects are recognised side effects of GLP-1 medicines rather than a disruption to the inner ear or vestibular system that drives true motion sickness. As a prescription-only medicine, Wegovy is started under clinical supervision, and your prescriber is the right person to help if these symptoms are troubling you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and it is a fair one. Motion sickness proper happens when your eyes and inner ear send conflicting signals to the brain, typically on a boat, in a car or on a winding road. Wegovy does not interfere with that system. What it does do is activate GLP-1 receptors in the gut and the brain, slowing the rate at which food leaves your stomach. When gastric emptying slows, nausea, bloating and a light-headed, queasy feeling can follow.
The result can feel very similar to travel sickness. You might feel worse in a moving vehicle, sitting in the back of a car, or when exposed to strong smells, because your already-unsettled stomach has less tolerance for additional provocation. That layering of triggers is real, even if the root cause is different. The NHS medicines page for semaglutide lists nausea, dizziness and vomiting among the most commonly reported side effects, particularly at the start of treatment and after each dose step up. Understanding which system is driving the symptom matters, because the remedies differ slightly.
If you are unsure whether your symptoms are related to Wegovy or something else, your prescriber is the right starting point. You can also read more about the broader side-effect profile of Wegovy to see how your experience fits the pattern.
For most people, nausea and related queasiness cluster around two predictable windows: the first two to three weeks after the very first injection, and the few days following each dose increase. GLP-1 medicines are titrated slowly on purpose, partly to give the gastrointestinal system time to adapt. At the lower starting doses, the effects on gastric motility are gentler; as the dose rises, the gut has to catch up again.
Clinical trial data from the STEP programme, published in the New England Journal of Medicine, showed that most gastrointestinal side effects with semaglutide were mild to moderate in severity and transient in nature. In practice, many people find that by the fourth or fifth week at any given dose their stomach has largely settled. The pattern does not always follow that timeline exactly, but it is a reasonable working expectation.
If nausea or dizziness is persistent, severe or accompanied by significant vomiting that is affecting hydration, that is worth discussing with your prescriber rather than waiting it out. For a more detailed look at how long sickness on Wegovy tends to last, we cover the typical timeline and what might extend it.
Several adjustments reliably reduce gut-related nausea on GLP-1 treatment, and they overlap usefully with the advice you would get for travel sickness prevention. Eating smaller amounts more slowly is probably the most effective single change. Large or fatty meals push a slowed stomach hardest, and the nausea that follows can linger for hours. Keeping meals light and protein-forward, particularly on the day of an injection, gives the gut less work to do.
Timing matters for travel specifically. Sitting in the front of a vehicle, fixing your gaze on a fixed point on the horizon, and keeping screens away all reduce the sensory mismatch that compounds queasiness. Cold fresh air through a window, staying hydrated with small frequent sips rather than large glasses, and avoiding strong food smells before or during a journey are all practical. Some people also find ginger tea or ginger biscuits genuinely helpful for mild nausea, though this is comfort rather than clinical evidence.
Alcohol and carbonated drinks tend to worsen reflux and bloating on semaglutide, so they are worth avoiding in the hours around travel. If you want to understand more about how Wegovy sickness typically presents and what drives it, that can help you identify your own triggers, and if you are already managing sickness and diarrhoea on Wegovy at the same time, keeping track of what makes symptoms better or worse is useful information to share with your prescriber at your next review.
Most people do not need to delay or skip an injection because of nausea, but there are situations where contacting your prescriber promptly makes sense. Severe or persistent vomiting that is making it hard to keep fluids down carries a risk of dehydration, which can affect kidney function. Signs of dehydration include feeling dizzy when you stand, very dark urine or passing very little. If you experience severe stomach pain that spreads to your back, with or without vomiting, seek urgent medical attention rather than waiting; this can be a symptom of pancreatitis, which the MHRA has flagged as a rare but serious side effect in its Drug Safety Update communications for GLP-1 medicines.
For milder, manageable queasiness, the usual advice is to mention it at your next clinical review so that the prescriber can consider whether a slower titration pace, a longer plateau at the current dose, or a dietary referral would help. No one should feel they have to push through unbearable symptoms. If you have questions that cannot wait, our aftercare team is available seven days a week.
At nume, a real prescriber reviews every consultation and every repeat order before anything is dispensed, which means there is always a clinical eye on how you are doing. If you are considering starting treatment and want to understand whether Wegovy is suitable for your situation, you can also read about Wegovy on our treatment overview or explore the wider range of weight-loss treatment options we offer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.